Pgi14 Perceived Value Assessment of Entecavir Versus Tenofovir in Chronic Hepatitis B

Value in Health- United Kingdom

doi 10.1016/j.jval.2011.02.1011

Full Text

Abstract

Available in

Categories

Occupational Health

Date

May 1, 2011

Authors

Publisher

Elsevier BV

Related search

Letter: Distinct Hepatitis B Virus Relapse Rates After Discontinuing Tenofovir and Entecavir Therapy in Chronic Hepatitis B Patients

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Tenofovir Plus Entecavir Combination Therapy for Chronic Hepatitis B With Nucleos(t)ide Analogue Failure

The European Research Journal

English

Comparison of Renal Safety and Efficacy of Telbivudine, Entecavir and Tenofovir Treatment in Chronic Hepatitis B Patients: Real World Experience

Clinical Microbiology and Infection

Infectious Diseases

English

Long-Term Outcome of Entecavir Therapy in Chronic Hepatitis B With Cirrhosis

Clinical Gastroenterology and Hepatology

Gastroenterology

English

Renal Concerns in the Treatment of Chronic Hepatitis B With Tenofovir

Journal of Renal and Hepatic Disorders

English

Entecavir Treatment of Chronic Hepatitis D

Clinical Infectious Diseases

Infectious Diseases

English

Obesity and Hepatocellular Carcinoma in Patients Receiving Entecavir for Chronic Hepatitis B

Clinical and molecular hepatology

Molecular Biology

English

Constipation During Entecavir Treatment in Chronic Hepatitis B Patients: Two Cases Reports

Archives of Hepatitis Research

English

Potential Effects of Telbivudine Versus Entecavir on Renal Function in Patients With Chronic Hepatitis B Virus Receiving Glucocorticoids Therapy

Therapeutic Apheresis and Dialysis

English